Allotiss.eu
About Allotiss.eu
Allotiss.eu is a Government & Social Sector company, and was acquired by LifeNet Health in February 2017. Foundation focused on providing allogeneic transplant services. Its focus areas include Healthcare and Healthcare Foundations.
Company details
Allotiss.eu foundation focused on providing allogeneic transplant services through providing healthcare solutions, and healthcare foundations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Stage Acquired
- SectorsGovernment & Social Sector
- Website allotiss.eu
- Acquired by LifeNet Health (Feb 2017)
- Investors
- Acquired byLifeNet Health
(Feb 2017)
Investors in Allotiss.eu
Allotiss.eu has secured backing from 1 investor. Prominent investors backing the company include LifeNet Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Allograft bio-implants are supplied for surgical and regenerative medicine uses. | 1982 | lifenethealth.org | Virginia Beach, United States |
Investor details for Allotiss.eu
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Allotiss.eu
Allotiss.eu foundation focused on providing allogeneic transplant services through providing healthcare solutions, and healthcare foundations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Allotiss.eu has 1 investor. Key investors include LifeNet Health.
Yes. Allotiss.eu was acquired by LifeNet Health in February 2017.